Table 1.
AEDs | Enhancement of GABA-mediated inhibition | Inhibition of glutamate excitation | Blockade of calcium channels | Blockade of sodium channels | Enhancement of potassium currents |
---|---|---|---|---|---|
RTG | + | NE | NE | NE | + |
VPA | +/− | + | + (T-type) | +/− | NE |
LTG | NE | + | + (N, P/Q, R, T) | + | NE |
TPM | + | + | + (L) | + | NE |
OXC | NE | NE | + (N, P) | + | NE |
CBZ | NE | NE | + (L) | + | NE |
TGB | + | NE | NE | NE | NE |
VGB | + | NE | NE | NE | NE |
GBP | + | NE | + (N, P/Q) | NE | NE |
Notes: +, well documented mechanism of action; NE, not effective at therapeutic AED concentrations; +/−, controversial results. Data are from Czuczwar and Patsalos,1 Czapinski et al,2 Sitges et al,6 Sitges et al,7 and Perucca.9
Abbreviations: AED, antiepileptic drug; CBZ, carbamazepine; GABA, γ-amino butyric acid; GBP, gabapentin; LTG, lamotrigine; OXC, oxcarbazepine; RTG, retigabine; TGB, tiagabine; TPM, topiramate; VGB, vigabatrin; VPA, valproate.